Clinical Trials Logo

Filter by:
NCT ID: NCT05171634 Completed - Ulcerative Colitis Clinical Trials

Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)

CUDISIA
Start date: May 5, 2021
Phase: N/A
Study type: Interventional

Prospective clinical study that analyzes the efficacy of colonoscopy assisted by an artificial intelligence system (DiscoveryTM) compared to virtual chromoendoscopy with iSCAN in the detection of colon dysplasia in patients with long-standing Ulcerative Colitis.

NCT ID: NCT05171153 Completed - Osteoporosis Clinical Trials

Analysis of Bone Quality in Adult Patients With Inflammatory Bowel Disease

Start date: October 1, 2021
Phase:
Study type: Observational

Inflammatory bowel disease (IBD) is considered a risk factor for the development of osteoporosis, which leads to an increased risk of fractures. There is no data on bone quality obtained with imaging techniques other than bone densitometry such as Trabecular Bone Score (TBS), 3D bone densitometry (DXA-3D) or quantitative bone ultrasound (QUS). The TBS study can provide information on bone microarchitecture in these patients, with TBS values expected to be lower than those of subjects without IBD, with a decrease of up to 50 points in this parameter. Primary objective: to evaluate and compare TBS values in patients with IBD and in a control group of volunteers without IBD or known metabolic bone pathology, adjusted for age, sex and body mass index (BMI). Secondary objectives: to evaluate and compare results in DEXA parameters, QUS, DEXA-3D, biochemical parameters and FRAX data between patients with IBD and controls. To evaluate the prevalence of vertebral fractures analyzed by VFA. As well as to evaluate the evolution in one year of all these parameters in patients with IBD. Prospective observational study with a cohort of patients with IBD and another of volunteers without IBD or metabolic bone pathology, adjusted for age, sex and BMI. Baseline bone quality data will be analyzed by bone densitometry, TBS, DEXA-3D and QUS, fractures assessed by VFA and bone remodeling markers in both cohorts. Subsequently, a one-year analysis of the parameters of the IBD cohort will be performed.

NCT ID: NCT05170737 Completed - Clinical trials for Safety, Tolerability, Pharmacokinetics of AEF0217

AEF0217 First-in-Human Phase I Study in 3 Parts (Single and Multiple Ascending Doses, and Food Effect) in Healthy Subjects.

AEF0217-101
Start date: October 1, 2021
Phase: Phase 1
Study type: Interventional

This trial is divided in 3 parts: FIH-SAD (Single Ascending Doses), FIH-MAD (Multiple Ascending Doses) and FIH-FE (Food effects). FIH-SAD will start first. The start of FIH-MAD will await the results of at least three cohorts from the FIHSAD study before initiated. The starting dose of the FIH-MAD will have been shown to be well tolerated and one dose level lower than the highest dose for which safety, tolerability and pharmacokinetic (PK) data are available. FIH-FE will be the last to start after the completion of FIH-SAD and conducted in parallel with parts of FIH-MAD.

NCT ID: NCT05170139 Completed - Caffeine Clinical Trials

The Effects of Caffeine on Physical Performance of Ice Hockey Players

cafhoc
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

To date, only one study has evaluated the effect of caffeine supplementation on athletic performance in ice hockey players finding a lack of ergogenic effect. This lack of effect is surprising as caffeine has been suggested to be an effective and safe nutritional supplement to improve physical performance in both trained and untrained individuals. Therefore, the aim of the present study is to evaluate the effect of acute caffeine ingestion (3mg/kg body mass). Thirteen elite adult ice-hockey male players will perform specific ice hockey performance tests in two separate days. On both occasions players will ingest 330 ml of water with lemon powertabs isostar® (86 kcal / 19g of carbohydrates) tablets, which will include in one of these days 3 mg/kg body mass of anhydrous caffeine. Players will perform a 35-m sprint, an agility test (Weave agility - slalom with puck), and a reaction test.

NCT ID: NCT05169216 Completed - Stress Clinical Trials

Cognitive-Behavioral Therapy on Junior Rowers

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

A quasi-experimental study was carried out with the complete team of the Spanish youth team of Rowing (n = 16). The setting where the intervention took place was during the concentration prior to the 2020 European Rowing Junior Championships. The final assessment was carried out the week before the championship (after finishing the 10th week of intervention). Psychological variables were assessed using the Psychological Characteristics Related to Sport Performance Questionnaire.

NCT ID: NCT05168917 Completed - Clinical trials for Inflammatory Bowel Diseases

EURECA (EUropeanRElapseCAlprotectin) Study

Start date: June 2, 2017
Phase: N/A
Study type: Interventional

This study will investigate the correlation of fecal calprotectin (FC) values to quiescent ulcerative colitis and to disease activity (relapse) as assessed by clinical data and endoscopy.

NCT ID: NCT05168436 Completed - Clinical trials for Renal Cell Carcinoma

A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal

Start date: August 5, 2019
Phase:
Study type: Observational

The purpose of this observational study is to determine patients' and professionals' preferences for the characteristics (attributes) of the treatment for Renal cell carcinoma (RCC) in Spain and Portugal.

NCT ID: NCT05168059 Completed - High Blood Pressure Clinical Trials

Clevidipine in Neurocritical Patients

NEURO-CLEV
Start date: January 1, 2017
Phase:
Study type: Observational

Acute blood pressure elevation is a frequent problem in neurocritical patients. Its effective management is challenging and must avoid significant decreases of blood pressure leading to lower cerebral perfusion pressure worsening ischemia and elevations probably associated with bleeding, rebleeding or hematoma expansion associated with poor prognosis

NCT ID: NCT05167500 Completed - Clinical trials for Metastatic Non Small Cell Lung Cancer

Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use Treatment

LORLAPULM
Start date: December 9, 2021
Phase:
Study type: Observational

This is an observational, non-interventional, retrospective, multicentre and nationwide study. The information will be obtained retrospectively, in most cases when the treatment has already ended. The primary objective of this study is determine the activity of lorlatinib (percentage of responses, duration of response, progression-free survival and time to treatment failure) of patients included in the compassionate use program in Spain.

NCT ID: NCT05167110 Completed - ADHD Clinical Trials

Nutritional Intervention for Children With ASD and/or ADHD

PRONED
Start date: February 3, 2020
Phase: N/A
Study type: Interventional

Based on alterations in the intestinal microbiota in children with ASD and the high comorbidity between ASD and ADHD, the aim of this project was to assess whether the administration of probiotics with strains related to the production of the neurotransmitters dopamine and GABA had a positive effect on social behavior, attention, and behavior.